Clinical Trial Update: PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting completion of a study evaluating two malaria vaccines, PpPfs25/ISA51 and ScPvs25/ISA51, for Plasmodium falciparum and Pl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• PpPfs25/ISA51
• ScPvs25/ISA51

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum, Plasmodium Vivax Malaria | Phase 1 | Status: COMPLETED